Home Teva, Active Biotech halt higher doses of oral MS drug in trials
 

Keywords :   


Teva, Active Biotech halt higher doses of oral MS drug in trials

2016-01-04 16:59:51| Biotech - Topix.net

Teva Pharmaceutical Industries and Active Biotech will discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients. Both trials of laquinimod will continue with the lower dose of 0.6 mg daily where there were no issues.

Tags: active higher drug oral

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11mont-bell
27.11HUUB L
27.11
27.11 6DVD
27.11 BIOM H4 BOA 41
27.11
27.11 MLABRI HAMMOCK
27.11
More »